These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 33008504)

  • 1. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
    Chiang CC; Schwedt TJ
    Prog Brain Res; 2020; 255():143-170. PubMed ID: 33008505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP and the Trigeminal System in Migraine.
    Iyengar S; Johnson KW; Ossipov MH; Aurora SK
    Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
    Walker CS; Hay DL
    Br J Pharmacol; 2013 Dec; 170(7):1293-307. PubMed ID: 23425327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Edvinsson L; Warfvinge K
    Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel migraine treatment with CGRP-related monoclonal antibodies].
    Shibata M
    Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
    Yuan H; White CS; Silberstein SD
    Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
    Cohen F; Yuan H; Silberstein SD
    BioDrugs; 2022 May; 36(3):341-358. PubMed ID: 35476215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-CGRP-based Migraine Medications: A Comprehensive Overview].
    Triller P; Raffaelli B
    Fortschr Neurol Psychiatr; 2024 Jul; 92(7-08):277-282. PubMed ID: 38547904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Yuan H; Spare NM; Silberstein SD
    Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP blockers in migraine therapy: where do they act?
    Edvinsson L
    Br J Pharmacol; 2008 Dec; 155(7):967-9. PubMed ID: 18776915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptides.
    Edvinsson L; Edvinsson JCA; Haanes KA
    Br J Pharmacol; 2022 Feb; 179(3):371-380. PubMed ID: 34411289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
    Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
    J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.